Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus

Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus

Individuals with human immunodeficiency virus (HIV) infection are prone to developing persistent and unremitting anogenital warts (AGWs). To address this health condition, immunotherapy using tuberculin purified protein derivative (PPD) has been proven to be a promising novel and safe treatment for...

Full description

Bibliographic Details
Main Authors:	Pati Aji Achdiat, Stephanie Widjaja, Oki Suwarsa, Reiva Farah Dwiyana, Reti Hindritiani, Endang Sutedja, Hendra Gunawan, Hermin Aminah Usman, Fathia Rianty, Retno Hesty Maharani
Format:	Article
Language:	English
Published:	PAGEPress Publications 2024-01-01
Series:	Dermatology Reports
Subjects:	Anogenital warts purified protein derivative immunotherapy human papillomavirus human immunodeficiency virus
Online Access:	https://www.pagepress.org/journals/index.php/dr/article/view/9754

Similar Items

Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article
by: Achdiat PA, et al.
Published: (2024-03-01)

Success of Intralesional Purified Protein Derivative Immunotherapy in the Treatment of Anogenital Warts: A Case Report
by: Achdiat PA, et al.
Published: (2022-04-01)

Successful treatment of anogenital warts with single dose Bacillus Calmette Guerin vaccine without prior sensitization in tuberculosis endemic country: Two case report
by: Pati Aji Achdiat, et al.
Published: (2023-01-01)

Treatment of Anogenital Warts: Siriraj Hospital Experience
by: Manopchai Thamkhantho, et al.
Published: (2020-04-01)

Increasing incidence of anogenital warts with an urban–rural divide among males in Manitoba, Canada, 1990–2011
by: Laura H. Thompson, et al.
Published: (2016-03-01)

Anogenital Warts in Geriatrics: Immunosenescence and New Sexual Contacts? A Case Report
by: Achdiat PA, et al.
Published: (2024-09-01)

The Oncogenic Human Papillomavirus Involvement as a Risk Factor of Measles, Mumps, and Rubella Vaccine Immunotherapy Failure in Anogenital Warts
by: Achdiat PA, et al.
Published: (2025-01-01)

Sustained Decline in Hospitalisations for Anogenital Warts in Australia: Analysis of National Hospital Morbidity Data 2003–2020
by: Harunor Rashid, et al.
Published: (2024-04-01)

Successful Treatment with Topical Diphenylcyclopropenone for Three Cases of Anogenital Warts in Children
by: Kazunori Miyata, et al.
Published: (2019-05-01)

Anogenital warts – the new treatment options
by: Joanna Salomon, et al.
Published: (2014-06-01)

A Case of Genital and Extragenital Warts Unresponsive to Immunotherapy Using Measles, Mumps, Rubella Vaccine
by: Achdiat PA, et al.
Published: (2023-11-01)

Prevalence and Type of Human Papillomavirus Infection in Thai Males with Anogenital Warts
by: Sukhum Jiamton, et al.
Published: (2023-06-01)

Viral metagenomics updated the prevalence of human papillomavirus types in anogenital warts
by: Hui Xu, et al.
Published: (2019-01-01)

Efficacy and safety of treating anogenital warts with intralesional vitamin D3 injection: a report on 20 Egyptian patients
by: Yasmin M Tawfik, et al.
Published: (2020-01-01)

Association of HPV genotypes with external anogenital warts: a cross sectional study
by: Rana Al-Awadhi, et al.
Published: (2019-05-01)

Healthcare resource utilization and costs associated with anogenital warts in Morocco
by: Myriam Berrada, et al.
Published: (2021-11-01)

Incidence of anogenital warts in Liuzhou, south China: a comparison of data from a prospective study and from the national surveillance system
by: Feixue Wei, et al.
Published: (2017-01-01)

HPV-associated anogenital condylomas: clinical-morphological aspects and therapy principles
by: N. M. Nazarova, et al.
Published: (2018-09-01)

Modern therapy of anogenital warts
by: A. A. Khryanin, et al.
Published: (2017-08-01)

Evaluation of Psychopathology and Quality of Life in Patients with Anogenital Wart Compared to Control Group
by: Mahsa Nahidi, et al.
Published: (2018-01-01)

Viral Metagenomics Reveals a Putative Novel HPV Type in Anogenital Wart Tissues
by: Huimin Hu, et al.
Published: (2022-12-01)

Lymphangioma of the vulva in a young woman, diagnosed previously as anogenital warts
by: Yulia N. Grekova, et al.
Published: (2023-01-01)

Prospective Longitudinal Study of Dynamics of Human Papillomavirus 6 and 11 Infection in Anogenital Hairs and Eyebrows of Male Patients with Anogenital Warts and Age-Matched Controls
by: Vesna Tlaker, et al.
Published: (2024-02-01)

Quality of life in patients with anogenital warts: A cross‐sectional study using the Dermatology Life Quality Index questionnaire
by: GC Sagar, et al.
Published: (2024-12-01)

The Effectiveness of Chemical Cautery and Electrosurgery on Anogenital Wart: Systematic Review
by: Mawardi P, et al.
Published: (2023-10-01)

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT
by: Richard Gilson, et al.
Published: (2020-09-01)

Clinical efficacy, safety and tolerance of the Kerawort (imiquimod) cream used for treatment of anogenital warts
by: M. R. Rakhmatulina, et al.
Published: (2017-08-01)

Letter to the Editor Regarding ‘A Multicentre, Randomised Clinical Trial to Compare a Topical Nitrizinc® Complex Solution Versus Cryotherapy for the Treatment of Anogenital Warts’
by: Antoine Bertolotti, et al.
Published: (2020-10-01)

A Multicentre, Randomised Clinical Trial to Compare a Topical Nitrizinc® Complex Solution Versus Cryotherapy for the Treatment of Anogenital Warts
by: Paolo Pontini, et al.
Published: (2020-07-01)

Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation
by: Elizabeth Thurgar, et al.
Published: (2016-03-01)

The psychosocial burden of anogenital warts on Syrian patients: study of quality of life
by: Joud Haddad, et al.
Published: (2022-07-01)

The Effectiveness of Genital Wart Treatments
by: Dilek Bıyık Özkaya, et al.
Published: (2023-09-01)

Cryotherapy alone versus cryotherapy followed by intralesional vitamin D3 in treatment of anogenital warts: a randomized comparative clinical study
by: Mohamed Azab, et al.
Published: (2023-01-01)

Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)
by: Macey L. Murray, et al.
Published: (2018-11-01)

Experience of using ustekinumab in the treatment of a patient with HIV-associated psoriasis and anogenital warts
by: M. I. Babkova, et al.
Published: (2021-12-01)

Factors Associated with Anogenital Warts and Gonorrhea Infection: A Cross-Sectional Study
by: Romina Faridizad, et al.
Published: (2022-01-01)

EFFICACY OF GENERIC DRUG WARTOCID® (IMIQUIMOD 5% CREAM FOR EXTERNAL USE) IN ANOGENITAL WARTS TREATMENT
by: V. S. Smirnova, et al.
Published: (2017-09-01)

Variations of Histone Acetyltransferase 300 in Patients with Human Papillomavirus Type 6-Associated Anogenital Warts
by: Mana zakeri, et al.
Published: (2020-11-01)

Wide Spectrum Analysis of Human Papillomavirus Genotypes in External Anogenital Warts
by: Orsolya Rideg, et al.
Published: (2021-06-01)

Epidemiological characteristics of papillomavirus infection of anogenital localization in Tatarstan republic
by: S. T. Agliullina, et al.
Published: (2022-10-01)